PLASMA ASPIRIN ESTERASE-ACTIVITY IN ELDERLY PATIENTS UNDERGOING ELECTIVE HIP-REPLACEMENT AND WITH FRACTURED NECK OF FEMUR

被引:19
作者
OMAHONEY, MS [1 ]
GEORGE, G [1 ]
WESTLAKE, H [1 ]
WOODHOUSE, K [1 ]
机构
[1] UNIV CARDIFF,CARDIFF ROYAL INFIRM,DEPT GERIATR MED,W WING,NEWPORT RD,CARDIFF CF2 1SZ,WALES
关键词
D O I
10.1093/ageing/23.4.338
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
Plasma aspirin esterase activity was measured in eight elderly patients undergoing elective hip replacement, and in 11 presenting with femoral-neck fracture. Elective hip surgery was associated with a marked and significant decline in esterase, from 330 +/- 35.9 (SE) (nmol salicylate/ml plasma/min) pre-operatively to 236 +/- 35.6 on the third post-operative day, and returning to normal (359 +/- 24.3) at recovery phase. Patients with fractured neck of femur showed a depressed esterase activity on admission (221 +/- 12.7), rising towards normal (290 +/- 15.4) on recovery. All of these changes were accompanied by a marked acute-phase response, both to injury and surgery. The data suggest that elderly patients experiencing injury or undergoing surgery may have significantly impaired drug metabolism, at least as far as this enzyme is concerned.
引用
收藏
页码:338 / 341
页数:4
相关论文
共 16 条
[1]
INCREASED RATES OF CORTISOL PRODUCTION AND URINARY FREE CORTISOL EXCRETION IN ELDERLY WOMEN 2 WEEKS AFTER PROXIMAL FEMUR FRACTURE [J].
BARTON, RN ;
WEIJERS, JWM ;
HORAN, MA .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (03) :171-176
[2]
PHARMACOKINETICS OF HIGH-DOSE PENTOBARBITAL IN SEVERE HEAD TRAUMA [J].
BAYLIFF, CD ;
SCHWARTZ, ML ;
HARDY, BG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :457-461
[3]
PHENYTOIN PHARMACOKINETICS IN CRITICALLY ILL TRAUMA PATIENTS [J].
BOUCHER, BA ;
RODMAN, JH ;
JARESKO, GS ;
RASMUSSEN, SN ;
WATRIDGE, CB ;
FABIAN, TC .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 44 (06) :675-683
[4]
EFFECT OF NEUROTRAUMA ON HEPATIC DRUG CLEARANCE [J].
BOUCHER, BA ;
KUHL, DA ;
FABIAN, TC ;
ROBERTSON, JT .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 50 (05) :487-497
[5]
FRUNCILLO RJ, 1984, J PHARM SCI, V78, P1117
[6]
GRIFFETH LK, 1983, DRUG METAB DISPOS, V11, P517
[7]
GRIFFETH LK, 1984, DRUG METAB DISPOS, V12, P582
[8]
GRIFFETH LK, 1984, DRUG METAB DISPOS, V12, P588
[9]
GRIFFETH LK, 1985, DRUG METAB DISPOS, V13, P398
[10]
GRIFFETH LK, 1987, DRUG METAB DISPOS, V15, P749